United Kingdom· GB-APID-8009311000001102
Curosurf 240mg/3ml endotracheopulmonary suspension vials
A medicinal product containing poractant alfa, registered in United Kingdom by Chiesi Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Poractant alfa
- Manufacturer
- Chiesi Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5028613002391
- gtin05028613002391
- gtin5028613003497
- gtin05028613003497
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Poractant alfa in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCurosurf 80 mg/ml Instillationsvätska för luftvägarna, suspensionChiesi Farmaceutici S.p.A.
- FinlandCurosurfOrifarm Oy
- IrelandCUROSURF 120 mg/vial Endotracheopulmonary instillation, suspensionChiesi Farmaceutici S.p.A.
- FranceCUROSURF 120 mg/1,5 ml, suspension pour instillation endotrachéobronchiqueCHIESI
- PolandCurosurfDelfarma Sp. z o.o.
- United StatesCurosurfChiesi USA, Inc.
- GermanyCurosurfChiesi Gmbh
- NorwayCurosurfChiesi Farmaceutici S.p.a.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Curosurf
- Belgium · Curosurf
- Bulgaria · Куросърф
- Cyprus · Curosurf
- Czechia · Curosurf
- Denmark · Curosurf
- Estonia · Curosurf
- Spain · Curosurf
- Finland · Curosurf
- France · Curosurf
- Greece · Curosurf
- Croatia · Curosurf
- Hungary · Curosurf
- Ireland · Curosurf
- Iceland · Curosurf
- Italy · Curosurf
- Lithuania · Curosurf
- Luxembourg · Curosurf
- Latvia · Curosurf
- Malta · Curosurf
- Netherlands · Curosurf
- Norway · Curosurf
- Poland · Curosurf
- Portugal · Curosurf
- Romania · Curosurf
- Sweden · Curosurf
- Slovenia · Curosurf
- Slovakia · Curosurf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa739cb1-4a06-4647-9605-28018bea52e5 GET /v1/drugs/aa739cb1-4a06-4647-9605-28018bea52e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "8009311000001102",
"desc": "Curosurf 240mg/3ml endotracheopulmonary suspension vials (Chiesi Ltd)",
"form": "Suspension for endotracheopulmonary instillation",
"vpid": "35898811000001106",
"source": "dmd",
"vtm_id": "777256006",
"strength": "80 mg",
"substance": "Poractant alfa",
"ingredient": "Poractant alfa",
"supplier_code": "9052511000001105"
}See everything about poractant alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.